These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1151116)

  • 1. An animal model for screening topical and systemic drugs for potential use in the treatment of psoriasis.
    du Vivier A; Stoughton RB
    J Invest Dermatol; 1975 Aug; 65(2):235-7. PubMed ID: 1151116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical drug effects on normal and proliferating epidermal cell models.
    Lowe NJ; Stoughton RB; McCullough JL; Weinstein GD
    Arch Dermatol; 1981 Jul; 117(7):394-8. PubMed ID: 7259217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse vaginal assay for topically effective chemotherapeutic agents.
    McCullough JL; Weinstein GD
    J Invest Dermatol; 1975 Oct; 65(4):394-9. PubMed ID: 1176790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local chemotherapy of psoriasis with nitrogen mustard].
    Touraine R; Revuz J; Boulvin F
    Ann Dermatol Syphiligr (Paris); 1973; 100(5-6):491-7. PubMed ID: 4802685
    [No Abstract]   [Full Text] [Related]  

  • 5. An animal model for screening drugs for antipsoriatic properties using hydroxyapatite to isolate DNA rapidly from the epidermis.
    du Vivier A; Bible R; Mikuriya RK; Stoughton RB
    Br J Dermatol; 1976 Jan; 94(1):1-6. PubMed ID: 1252332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical mechlorethamine for psoriasis. An attempt to avoid the development of sensitization by the use of a topical tolerogenic schedule.
    Price NM
    Int J Dermatol; 1979 Jun; 18(5):390-3. PubMed ID: 468460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the hairless mouse screening model for antipsoriatic drugs.
    Zmolek WW; Chao WR; Miller JP
    Br J Dermatol; 1983 Jan; 108(1):25-31. PubMed ID: 6681584
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of psoriasis with topical nitrogen mustard.
    Handler RM; Medansky RS
    Int J Dermatol; 1979 Nov; 18(9):758-61. PubMed ID: 511440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and experimental investigations on the effect of cytostatic drugs in psoriasis.
    Caccialanza P; Finzi AF
    Ital Gen Rev Dermatol; 1974; 11(1):37-46. PubMed ID: 4143394
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokinetics and chemotherapy of psoriasis.
    Weinstein GD; McCullough JL
    J Invest Dermatol; 1976 Jul; 67(1):26-30. PubMed ID: 778295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [External use of cytostatics in psoriasis].
    Datskovskiĭ BM; Masetkin IP; Osnovina NG
    Vestn Dermatol Venerol; 1975 Sep; (9):70-3. PubMed ID: 1231367
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical screening program for topical chemotherapeutic drugs in psoriasis.
    Weinstein GD; McCullough JL; Eaglstein WH; Golub A; Cornell RC; Stoughton RB; Clendenning W; Zackheim H; Maibach H; Kulp KR; King L; Baden HP; Taylor JS; Deneau DD
    Arch Dermatol; 1981 Jul; 117(7):388-93. PubMed ID: 6789777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute tolerance to effects of topical glucocorticosteroids.
    Vivier AD; Stoughton RB
    Br J Dermatol; 1976 Mar; 94 suppl 12():25-32. PubMed ID: 1268076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New immunosuppresor strategies in the treatment of murine lupus nephritis.
    Alperovich G; Rama I; Lloberas N; Franquesa M; Poveda R; Gomà M; Herrero-Fresneda I; Cruzado JM; Bolaños N; Carrera M; Grinyó JM; Torras J
    Lupus; 2007; 16(1):18-24. PubMed ID: 17283580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
    Leer JA
    Clin Ther; 1980; 3(3):156-67. PubMed ID: 7006810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
    Ambaye RY; Indap MA
    Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
    Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
    J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclophosphamide on development of experimental cholesteatoma.
    Pownell PH; Wright CG; Robinson KS; Meyerhoff WL
    Arch Otolaryngol Head Neck Surg; 1994 Oct; 120(10):1114-6. PubMed ID: 7917193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.
    Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for recurrent carcinoma of the breast.
    Humphrey LJ; Jewell WR
    Oncology; 1972; 26(2):223-30. PubMed ID: 4626138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.